Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BVS
BVS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BVS News
Conexeu Sciences Inc. Begins Trading on Nasdaq
May 22 2026
PRnewswire
Conexeu Sciences Inc. Successfully Debuts on Nasdaq
May 22 2026
Newsfilter
Bioventus (BVS) Q1 2026 Earnings Transcript
May 06 2026
NASDAQ.COM
Bioventus Q1 2026 Earnings Call Highlights
May 06 2026
seekingalpha
Bioventus Q1 Earnings Exceed Expectations
May 06 2026
seekingalpha
Bioventus Reports 7% Revenue Growth in Q1
May 06 2026
Newsfilter
TELA Bio Announces Board Refreshment Plan for Growth
Apr 30 2026
Globenewswire
Bioventus Q4 2025 Earnings Call Highlights
Mar 05 2026
seekingalpha
Bioventus (BVS) Q4 2025 Earnings Call Transcript
Mar 05 2026
NASDAQ.COM
Bioventus Reports Q4 2025 Financial Results with Strong Growth
Mar 05 2026
Newsfilter
Bioventus Releases Financial Guidance for FY 2026
Mar 05 2026
seekingalpha
Wall Street Analysts Adjust Ratings on Key Stocks
Feb 09 2026
Benzinga
BIOVENTUS INC: BARRINGTON RESEARCH STARTS COVERAGE WITH OUTPERFORM RATING AND SETS PRICE TARGET AT $13
Feb 09 2026
moomoo
Bravura Solutions Projects FY2026 Revenue of A$265-275 Million Amid Insider Buying
Jan 01 2026
Yahoo Finance
BioVersys Initiates BV100 Phase 3 Clinical Trial, Raises CHF 76.7 Million in IPO
Dec 11 2025
Globenewswire
Halper Sadeh Investigates Bioventus for Potential Shareholder Compensation
Dec 05 2025
PRnewswire
Show More News
